ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,310Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 2588

$968K Total Retail Price of All Prescriptions

Rank: 96 out of 2588

504 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

23% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 12,777 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 645 520 1 5
HYDROCODONE-ACETAMINOPHEN 580 283 S3 2 7
SIMVASTATIN 561 503 3 1
TRAMADOL HCL 488 306 4 19
LISINOPRIL 463 320 5 3
POTASSIUM CHLORIDE 454 368 6 15
CITALOPRAM HBR 449 308 7 27
OMEPRAZOLE 445 329 8 6
AMLODIPINE BESYLATE 426 308 9 4
LEVOTHYROXINE SODIUM 391 339 10 2
GABAPENTIN 378 276 11 18
ATORVASTATIN CALCIUM 312 228 12 11
CARVEDILOL 285 224 13 20
ATENOLOL 280 241 14 14
ZOLPIDEM TARTRATE 277 108 15 24
PRAVASTATIN SODIUM 276 224 16 16
METFORMIN HCL ER 267 192 17 67
GLIMEPIRIDE 267 221 17 39
CRESTOR 223 98 19 25
LOSARTAN POTASSIUM 206 157 20 17
AZITHROMYCIN 203 146 21 45
ISOSORBIDE MONONITRATE ER 169 142 22 49
METOPROLOL TARTRATE 162 107 23 9
CYCLOBENZAPRINE HCL 162 88 R 23 87
TRAZODONE HCL 155 123 25 61
RANITIDINE HCL 152 99 26 37
CLOPIDOGREL 149 124 27 30
PROAIR HFA 148 84 28 50
WARFARIN SODIUM 133 118 29 10
OXYCODONE-ACETAMINOPHEN 131 96 S2 30 218
ALLOPURINOL 131 126 30 33
NAMENDA 128 124 32 32
METFORMIN HCL 120 101 33 8
NEXIUM 115 70 34 41
ROPINIROLE HCL 112 99 35 113
ZOSTAVAX 111 106 36 312
PREDNISONE 110 83 37 42
PLAVIX 109 89 38 43
SERTRALINE HCL 108 61 39 26
LYRICA 105 69 40 100
SINGULAIR 104 74 41 94
METOPROLOL SUCCINATE 103 88 42 12
PEN NEEDLE 101 77 43 112
PANTOPRAZOLE SODIUM 98 86 44 28
MELOXICAM 97 59 45 51
HYDRALAZINE HCL 96 80 46 53
CIPROFLOXACIN HCL 93 65 47 82
FENTANYL 93 74 S2 47 78
CLONIDINE HCL 92 79 49 54
NORTRIPTYLINE HCL 92 84 49 237
AMITRIPTYLINE HCL 90 72 R 51 91
TAMSULOSIN HCL 89 80 52 23
MECLIZINE HCL 88 71 53 120
TRIAMTERENE-HCTZ 88 66 53 46
DIOVAN 86 75 55 29
HYDROCHLOROTHIAZIDE 83 77 56 13
LANTUS SOLOSTAR 81 66 57 93
BENAZEPRIL HCL 78 60 58 84
POLYETHYLENE GLYCOL 3350 77 62 59 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 56 59 35
ADVAIR DISKUS 77 61 59 48
PAROXETINE HCL 76 62 62 71
CYMBALTA 75 31 63 70
LOSARTAN-HYDROCHLOROTHIAZIDE 75 62 63 66
OXYBUTYNIN CHLORIDE ER 73 53 65 85
SPIRIVA 71 41 66 56
CEPHALEXIN 71 47 66 138
NABUMETONE 70 25 68 147
MONTELUKAST SODIUM 66 47 69 153
OXYBUTYNIN CHLORIDE 64 56 70 132
AMLODIPINE BESYLATE-BENAZEPRIL 63 43 71 76
FLUCONAZOLE 61 41 72 277
BUMETANIDE 60 37 73 117
FLUOXETINE HCL 60 34 73 92
DONEPEZIL HCL 59 59 75 22
QUETIAPINE FUMARATE 58 54 76 74
BACLOFEN 56 25 77 142
ALENDRONATE SODIUM 55 55 78 21
MIRTAZAPINE 54 54 79 63
LIPITOR 51 30 80 114
CARBIDOPA-LEVODOPA 51 51 80 83
INSULIN SYRINGE 51 39 80 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 15, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.